Zivo Bioscience, Inc.
ZIVO
$14.85
-$0.15-1.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.62% | -130.39% | -72.11% | -60.90% | -52.48% |
| Total Depreciation and Amortization | 8.02% | 8.02% | 8.02% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -98.87% | 4.56% |
| Total Other Non-Cash Items | -30.46% | 7,493.24% | 5,603.55% | 629.14% | 467.10% |
| Change in Net Operating Assets | 139.79% | -128.09% | -139.08% | 96.17% | -87.95% |
| Cash from Operations | 22.18% | 24.68% | 25.63% | 36.86% | 17.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -26.87% | -70.72% | -70.52% | -58.42% | -58.42% |
| Total Debt Repaid | 66.65% | 67.70% | 69.35% | -176.21% | -177.57% |
| Issuance of Common Stock | -33.94% | -16.35% | 31.05% | 5.03% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -21.74% | -16.54% | 30.57% | -39.56% | 405.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.71% | 641.34% | 183.15% | 30.30% | 99.63% |